InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Wednesday, 12/19/2012 8:35:16 AM

Wednesday, December 19, 2012 8:35:16 AM

Post# of 130513
"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.